Imidapril - Wikipedia
网页Imidapril, sold under the brand name Tanatril among others, is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure. It was patented in 1982 and approved for medical use in 1993.
咪达普利 - 维基百科，自由的百科全书
网页咪达普利（英語： Imidapril ）商品名：达爽，是一款血管紧张素转化酶抑制剂 抗高血压药物，在1993年由日本田边制药研制并投入市场。 [1] 咪达普利口服后，在体内转换成活性代谢物咪达普利拉（Imidaprilat）。
Imidapril: Uses, Interactions, Mechanism of Action - DrugBank …
网页2016年10月20日 · Imidapril is an ACE inhibitor used in the treatment of essential hypertension. Generic Name Imidapril DrugBank Accession Number DB11783 Background. Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant. Type Small Molecule Groups Investigational Structure
Imidapril: Uses, Dosage, Side Effects and More - MIMS
网页Mechanism of Action: Imidapril, a prodrug of imidaprilat, is a competitive ACE inhibitor that prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor responsible for arterial vasoconstriction, increased blood pressure, and stimulation of aldosterone secretion.
Imidapril | C20H27N3O6 | CID 5464343 - PubChem
网页Imidapril is an angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, imidapril is converted by hydrolysis in the liver into its active form imidaprilat. Imidaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II.
Tanatril. Imidapril for high blood pressure - Patient
网页2022年10月26日 · About imidapril. Imidapril belongs to a class of medicines called angiotensin-converting enzyme (ACE) inhibitors. You will have been prescribed it to reduce high blood pressure, a condition called hypertension. ACE inhibitors like imidapril prevent your body from creating a hormone known as angiotensin II.
Imidapril: a review of its use in essential hypertension, Type 1 ...
网页In clinical trials, oral imidapril was an effective antihypertensive agent in the treatment of mild to moderate essential hypertension. Some evidence suggests that imidapril also improves exercise capacity in patients with chronic heart failure (CHF) and reduces urinary albumin excretion rate in patients with type 1 diabetes mellitus.
Safety and Efficacy of Imidapril in the Treatment of Essential ...
网页2011年11月1日 · A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Imidapril - an overview | ScienceDirect Topics
网页Imidapril is a long-acting, non-sulfhydryl ACE inhibitor that has been used in patients with hypertension, congestive heart failure, acute myocardial infarction, and diabetic nephropathy. It is a prodrug, rapidly converted in the liver to its active metabolite imidaprilat, which has a half-life of about 15 hours.
NCATS Inxight Drugs — IMIDAPRIL
网页Imidapril (Tanatril), through its active metabolite imidaprilat, acts as an ACE inhibitor to suppress the conversion of angiotensin I to angiotensin II and thereby reduce total peripheral resistance and systemic blood pressure (BP). In clinical trials, oral imidapril was an effective antihypertensive agent in the treatment of mild to moderate ...
跳至内容